Understanding different types of diabetes to improve prevention and treatment
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
This study is looking at different types of diabetes and prediabetes to find better ways to treat each person based on their unique body characteristics, so if you have diabetes or prediabetes, your treatment can be more personalized and effective just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11051066 on NIH RePORTER |
What this research studies
This research investigates the various physiological subtypes of diabetes and prediabetes to enhance personalized treatment approaches. By analyzing biological markers and metabolic processes, the study aims to classify individuals based on their unique physiological characteristics rather than just clinical symptoms. This could lead to more effective prevention strategies and targeted therapies tailored to each patient's specific needs. The research employs advanced multi-omics techniques to gather comprehensive data on participants' metabolic functions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with prediabetes or early-stage type 2 diabetes.
Not a fit: Patients with type 1 diabetes or those who do not have prediabetes or early-stage type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective diabetes prevention and treatment strategies for patients.
How similar studies have performed: Previous research has shown promise in using multi-omics approaches to understand diabetes heterogeneity, indicating potential for success in this novel investigation.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mclaughlin, Tracey — Stanford University
- Study coordinator: Mclaughlin, Tracey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.